Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates
-
GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024
-
Lulus Reports Third Quarter 2024 Results
-
Alumis Reports Third Quarter 2024 Financial Results and Highlights Recent Achievements
-
StoneX Group Inc. to Announce 2024 Fiscal Fourth Quarter Earnings on November 19, 2024
-
NextNav Inc. Reports Third Quarter 2024 Results
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024
-
DMC Global Announces Michael Kuta to Retire as President, CEO and Director; Executive Chairman James O’Leary Will Serve as Interim President & CEO
-
Kura Sushi USA Announces Closing of $68.0 Million Public Offering of Common Stock
-
BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results
-
Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
STRATA Skin Sciences Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
-
Alvotech Reports Financial Results for the First Nine Months of 2024
-
Leslie’s, Inc. to Report Fourth Quarter and Full Year Fiscal 2024 Financial Results on November 25, 2024
-
The Ensign Group to Present at the Stephens Annual Investment Conference on November 20, 2024
-
The Oncology Institute Reports Third Quarter 2024 Financial Results
-
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
-
Structure Therapeutics Reports Third Quarter 2024 Financial Results and Recent Highlights
-
LPL Financial Hosts Program Leadership Conference for Top Bank and Credit Union Program Executives
-
Old National Bancorp Announces Quarterly Dividends
-
Glass House Brands Reports Record Setting Third Quarter 2024 Financial Results
-
Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results
-
OptimizeRx Reports Third Quarter 2024 Financial Results
-
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
-
Jones Soda Reports Third Quarter 2024 Results
-
Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
-
Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives
-
Roadzen Reports Fiscal Second Quarter and First Half FY2025 Financial Results
-
Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
-
Safe Bulkers, Inc. Reports Third Quarter 2024 Results and Declares Dividend on Common Stock
-
Annexon Biosciences to Present at the Jefferies London Healthcare Conference
-
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast
-
Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
-
Akero Therapeutics to Present at the Jefferies London Healthcare Conference
-
Flywire to Attend Upcoming Investor Conferences
-
4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
-
Espey Mfg. & Electronics Corp. reports first quarter results
-
Alvotech Reports Financial Results for the First Nine Months of 2024
-
Ibotta Reports Third Quarter 2024 Financial Results
-
AirJoule Technologies Announces Third Quarter 2024 Results
-
Conifer Holdings Reports 2024 Third Quarter Financial Results
-
Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
-
electroCore Announces Third Quarter 2024 Financial Results
-
Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
-
Synaptics Incorporated Announces Proposed Convertible Senior Notes Offering
-
Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update


